NO941458L - - Google Patents

Info

Publication number: NO941458L
Authority: NO; Norway
Prior art keywords: burgdorferi; polypeptide; relates; lyme; disease
Prior art date: 1991-10-22

Application number

NO941458A

Other languages

English (en)

Norwegian (no)

Other versions

NO941458D0 (no

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-22

Filing date

1994-04-21

Publication date

1994-04-21

1991-10-22 Priority claimed from US07/781,355 external-priority patent/US5246844A/en

1994-04-21 Application filed filed Critical

1994-04-21 Publication of NO941458D0 publication Critical patent/NO941458D0/no

1994-04-21 Publication of NO941458L publication Critical patent/NO941458L/no

Links

241000589969 Borreliella burgdorferi Species 0.000 abstract 3
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
208000016604 Lyme disease Diseases 0.000 abstract 2
101710159910 Movement protein Proteins 0.000 abstract 2
108020004414 DNA Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002649 immunization Methods 0.000 abstract 1
238000003018 immunoassay Methods 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Peptides Or Proteins (AREA)

NO941458A 1991-10-22 1994-04-21 Virulensbetingende proteiner i Borrelia Burgdorferi (Bb) NO941458D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/781,355 US5246844A (en)	1991-10-22	1991-10-22	Virulence associated proteins in borrelia burgdorferi (bb)
PCT/US1992/009145 WO1993008286A1 (en)	1991-10-22	1992-10-21	VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb)

Publications (2)

Publication Number	Publication Date
NO941458D0 NO941458D0 (no)	1994-04-21
NO941458L true NO941458L (es)	1994-04-21

Family

ID=26785129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO941458A NO941458D0 (no)	1991-10-22	1994-04-21	Virulensbetingende proteiner i Borrelia Burgdorferi (Bb)

Country Status (1)

Country	Link
NO (1)	NO941458D0 (es)

1994
- 1994-04-21 NO NO941458A patent/NO941458D0/no unknown

Also Published As

Publication number	Publication date
NO941458D0 (no)	1994-04-21

Similar Documents

Publication	Publication Date	Title
CN1328286C (zh)	2007-07-25	无糖产物和使用方法
Darcy et al.	1992	Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen
ATE210296T1 (de)	2001-12-15	Immunologisches nachweisverfahren von antikörpern,die gegen gewebe-transglutaminase (ttg) gerichtet sind, verwendung von ttg zur diagnose und therapiekontrolle sowie orales pharmazeutisches mittel enthaltend ttg
EP0909814A3 (en)	2003-02-26	Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
ATE440861T1 (de)	2009-09-15	Immunisierung gegen chlamydia pneumoniae
EA007409B1 (ru)	2006-10-27	Антигенные полипептиды стрептококков, способы их получения и применения
WO1995014781A3 (en)	1995-06-22	Methods for diagnosing early lyme disease
MX2011000134A (es)	2011-04-05	Vacuna contra el intermediario de plegamiento amiloide.
DE60024092T2 (de)	2006-08-03	Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
CA2294701A1 (en)	1999-01-07	Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
Ewing et al.	1990	Antibody activity in ankylosing spondylitis sera to two sites on HLA B27. 1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199).
EP0896583A1 (en)	1999-02-17	Novel osp-c derived peptide fragments
JPH0710774A (ja)	1995-01-13	スプレプトコッカス・スイス感染に対するワクチン
JP2003520765A (ja)	2003-07-08	ポルフィロモナス・ジンジヴァリスによる歯周炎の治療及び予防のための保護エピトープを含有する合成ペプチド
SI0998556T1 (en)	2005-10-31	Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
DE69031351D1 (de)	1997-10-02	Zubereitungen und behandlungen von pneumonia in tieren
Parr et al.	1995	Purification and measurement of secretory IgA in mouse milk
NO943811L (no)	1994-12-06	T-celle-epitoper av hovedallergenene fra Ambriosa artemisiifolia
PT1219301E (pt)	2007-09-04	Vacinas contendo polipéptidos híbridos, consistindo em, pelo menos, duas proteínas alergénicas diferentes
WO1992021697A3 (en)	1993-05-13	Diagnostic peptides derived from m.tuberculosis antigens
WO2002081625A3 (en)	2003-05-22	Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
WO2002099062A3 (en)	2003-02-20	Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US20040156865A1 (en)	2004-08-12	M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
CA2123694A1 (en)	1993-06-10	Peptides and antibodies for treatment of rheumatoid arthritis
WO2002090504A3 (en)	2004-08-12	Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use